文献速递心脑血管急症

光学相干断层扫描指导与血管造影指导的经皮冠状动脉介入治疗复杂病变患者:OCCUPI 研究者发起、多中心、随机、开放标签、优效性试验(韩国)

Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
PubMed 文献 · Lancet · 2024-09-02
一句话结论在复杂冠脉病变行药物洗脱支架 PCI 的患者中,OCT 指导较血管造影指导降低 1 年主要不良心脏事件(5% vs 7%,HR 0.62,95%CI 0.41–0.93,p=0.023)。

OCCUPI 为研究者发起、多中心、随机、开放标签、优效性试验,在韩国 20 家医院纳入 19–85 岁、临床有药物洗脱支架 PCI 指征且造影后确认至少一处复杂病变的患者 1604 例,1:1 随机接受 OCT 指导 PCI(n=803)或不用 OCT 的血管造影指导 PCI(n=801)。主要终点为 PCI 后 1 年主要不良心脏事件(心源性死亡、心肌梗死、支架血栓或缺血驱动的靶血管血运重建)复合终点,在意向治疗人群中分析,优效性界值为风险比 1.0。OCT 组主要终点 37 例(5%)vs 血管造影组 59 例(7%)(绝对差 -2.8%[95%CI -5.1 至 -0.4];HR 0.62[95%CI 0.41 至 0.93];p=0.023)。卒中、出血事件和造影剂肾病发生率两组无显著差异。作者认为,在复杂冠脉病变需药物洗脱支架植入的患者中,OCT 指导较血管造影指导降低 1 年主要不良心脏事件发生率。

要点

  • 复杂冠脉病变行药物洗脱支架 PCI 时,OCT 指导组 1 年主要不良心脏事件 5%(37/803)vs 血管造影指导组 7%(59/801),绝对差 -2.8%(95%CI -5.1 至 -0.4),HR 0.62(95%CI 0.41 至 0.93),p=0.023。
  • 主要终点为心源性死亡、心肌梗死、支架血栓或缺血驱动的靶血管血运重建的复合终点,PCI 后 1 年评估,意向治疗人群分析,优效性界值为 HR 1.0。
  • 卒中、出血事件和造影剂肾病发生率两组无显著差异。
  • 1588 例(99%)完成 1 年随访;患者中男性 1290 例(80%)、女性 314 例(20%),随机时中位年龄 64 岁(IQR 57–70)。
  • 作者认为,这些发现表明 OCT 作为血管内成像技术用于复杂冠脉病变 PCI 指导存在治疗获益。

适用人群与场景

  • 年龄 19–85 岁、临床有药物洗脱支架 PCI 指征的患者,诊断性血管造影后经临床和造影评估确认存在一处或以上复杂病变。
  • 韩国 20 家医院参加;随机分组时中位年龄 64 岁(IQR 57–70),男性 1290 例(80%)、女性 314 例(20%)。

诊断标准与关键阈值

  • 复杂病变标准:诊断性血管造影后经临床和造影评估,存在一处或以上复杂病变。
  • 主要终点:PCI 后 1 年主要不良心脏事件,即心源性死亡、心肌梗死、支架血栓或缺血驱动的靶血管血运重建的复合终点。
  • 优效性界值为风险比 1.0。

处置流程与药物剂量

  • 按常规标准方法行 PCI,使用依维莫司洗脱支架。
  • OCT 指导组在 OCT 指导下行 PCI;血管造影指导组不用 OCT、仅以血管造影指导行 PCI。
  • 随机化:各中心采用网络应答置换区组随机化(混合区组 4 或 6),1:1 分配;分配序列由未参与试验其余部分的外部程序员计算机生成。
  • 结局评估者对分组设盲;患者、随访医疗提供者和数据分析者不设盲。

研究设计与关键结果

  • 研究类型:研究者发起、多中心、随机、开放标签、优效性试验,韩国 20 家医院,2019 年 1 月 9 日至 2022 年 9 月 22 日随机 1604 例,OCT 指导组 n=803、血管造影指导组 n=801。
  • 主要终点(意向治疗人群):OCT 指导组 37/803(5%)vs 血管造影指导组 59/801(7%),绝对差 -2.8%(95%CI -5.1 至 -0.4),HR 0.62(95%CI 0.41 至 0.93),p=0.023。
  • 1588/1604(99%)完成 1 年随访;卒中、出血事件和造影剂肾病发生率两组无显著差异。
  • 试验注册号 ClinicalTrials.gov NCT03625908,已完成。

证据类型、等级与局限

  • 证据类型:多中心随机开放标签优效性试验(RCT),意向治疗分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在复杂冠脉病变需药物洗脱支架植入的患者中,OCT 指导较血管造影指导降低 1 年主要不良心脏事件发生率,表明 OCT 作为血管内成像技术用于 PCI 指导存在治疗获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Despite the detailed imaging information provided by optical coherence tomography (OCT) during percutaneous coronary intervention (PCI), clinical benefits of this imaging technique in this setting remain uncertain. The aim of the OCCUPI trial was to compare the clinical benefits of OCT-guided versus angiography-guided PCI for complex lesions, assessed as the rate of major adverse cardiac events at 1 year.

METHODS: This investigator-initiated, multicentre, randomised, open-label, superiority trial conducted at 20 hospitals in South Korea enrolled patients aged 19-85 years for whom PCI with drug-eluting stents was clinically indicated. After diagnostic angiography, clinical and angiographic findings were assessed to identify patients who met the criterion of having one or more complex lesions. Patients were randomly assigned 1:1 to receive PCI with OCT guidance (OCT-guidance group) or angiography guidance without OCT (angiography-guidance group). Web-response permuted-block randomisation (mixed blocks of four or six) was used at each participating site to allocate patients. The allocation sequence was computer-generated by an external programmer who was not involved in the rest of the trial. Outcome assessors were masked to group assignment. Patients, follow-up health-care providers, and data analysers were not masked. PCI was done according to conventional standard methods with everolimus-eluting stents. The primary endpoint was major adverse cardiac events (a composite of cardiac death, myocardial infarction, stent thrombosis, or ischaemia-driven target-vessel revascularisation), 1 year after PCI. The primary analysis was done in the intention-to-treat population. The margin used to establish superiority was 1·0 as a hazard ratio. This trial is registered with ClinicalTrials.gov (NCT03625908) and is completed.

FINDINGS: Between Jan 9, 2019, and Sept 22, 2022, 1604 patients requiring PCI with drug-eluting stents for complex lesions were randomly assigned to receive either OCT-guided PCI (n=803) or angiography-guided PCI (n=801). 1290 (80%) of 1604 patients were male and 314 (20%) were female. The median age of patients at randomisation was 64 years (IQR 57-70). 1588 (99%) patients completed 1-year follow-up. The primary endpoint occurred in 37 (5%) of 803 patients in the OCT-guided PCI group and 59 (7%) of 801 patients in the angiography-guided PCI group (absolute difference -2·8% [95% CI -5·1 to -0·4]; hazard ratio 0·62 [95% CI 0·41 to 0·93]; p=0·023). Rates of stroke, bleeding events, and contrast-induced nephropathy were not significantly different across the two groups.

INTERPRETATION: Among patients who required drug-eluting stent implantation for complex lesions, OCT guidance resulted in a lower incidence of major adverse cardiac events at 1 year compared with angiography guidance. These findings indicate the existence of a therapeutic benefit of OCT as an intravascular imaging technique for PCI guidance in patients with complex coronary lesions.

FUNDING: Abbott Vascular and Cardiovascular Research Center.

TRANSLATION: For the Korean translation of the abstract see Supplementary Materials section.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Hong SJ, Lee SJ, Lee SH, et al. Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea. Lancet. 2024. PMID: 39236729. doi:10.1016/S0140-6736(24)01454-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。